| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $118,766,946 ) (Continued on the next page) |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI045050 | Characterization of SLE-susceptibility loci on mouse chromosome 1 | 000 | 26 | NIH | 5/26/2026 | $721,482 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133463 | Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity | 000 | 4 | NIH | 3/9/2026 | $528,581 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL175081 | Characterize TMEM94 as ER Mg2+ uptake machinery and pathophysiological consequences. | 000 | 2 | NIH | 5/12/2026 | $529,902 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U19AG076581 | Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations | 002 | 4 | NIH | 9/4/2026 | $1,823,594 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U19AG076581 | Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations | 001 | 4 | NIH | 8/26/2026 | $3,973,798 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH127216 | Neural connectivity before and after each of the three treatment phases of trauma-focused therapy for adolescent posttraumatic stress | 000 | 5 | NIH | 1/27/2026 | $775,052 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM160303 | Molecular Architecture and Function of synaptic AMPA receptor complexes | 000 | 2 | NIH | 6/26/2026 | $433,125 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R34HL177446 | TranExamic Atomized for Pediatric post-Operative Tonsillectomy hemorrhage (TEAPOT) | 000 | 2 | NIH | 6/23/2026 | $356,249 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | P30AG044271 | San Antonio Claude D. Pepper Older Americans Independence Center | 003 | 12 | NIH | 8/3/2026 | $1,291,189 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI185790 | Lymphotoxin-dependent control of long COVID | 000 | 1 | NIH | 2/13/2026 | $234,715 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262757 | Enhancing endoplasmic reticulum stress in ovarian cancer | 000 | 5 | NIH | 3/5/2026 | $527,072 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM128731 | Structure and Function of the Essential Cell Cycle Regulator Cdc34 | 000 | 9 | NIH | 2/12/2026 | $319,302 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01AG022307 | Center for Testing Potential Anti-Aging Interventions | 000 | 23 | NIH | 6/23/2026 | $1,546,778 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 001 | 2 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 000 | 2 | NIH | 2/5/2026 | $39,070 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 009 | 2 | NIH | 3/2/2026 | $578,469 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 009 | 2 | NIH | 3/2/2026 | -$578,469 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 005 | 2 | NIH | 2/23/2026 | $154,789 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 008 | 2 | NIH | 3/2/2026 | $267,160 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 004 | 2 | NIH | 2/20/2026 | $578,469 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 008 | 2 | NIH | 3/2/2026 | -$267,160 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 003 | 2 | NIH | 2/19/2026 | $267,160 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 007 | 2 | NIH | 3/2/2026 | $338,964 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 002 | 2 | NIH | 2/18/2026 | $338,964 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 007 | 2 | NIH | 3/2/2026 | -$338,964 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 001 | 2 | NIH | 2/17/2026 | $102,360 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 010 | 2 | NIH | 3/2/2026 | $154,789 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 006 | 2 | NIH | 3/2/2026 | $102,360 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 000 | 2 | NIH | 2/13/2026 | $3,267,462 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 010 | 2 | NIH | 3/2/2026 | -$154,789 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 006 | 2 | NIH | 3/2/2026 | -$102,360 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK144299 | Role of OxPLs-mediated oxidative damage in MASH | 000 | 1 | NIH | 5/5/2026 | $639,990 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31AI200335 | Investigating The Role of The Human Mannose Receptor (CD206) During M. tuberculosis Infection in a Novel Transgenic Mouse | 001 | 1 | NIH | 5/13/2026 | $0 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA299621 | Development of first-in-class AAK1 PROTACs for ovarian cancer | 000 | 1 | NIH | 3/25/2026 | $593,338 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31AI200335 | Investigating The Role of The Human Mannose Receptor (CD206) During M. tuberculosis Infection in a Novel Transgenic Mouse | 000 | 1 | NIH | 5/13/2026 | $40,114 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI196999 | Dissecting the role of CD36 on Tbet+ B cells during obesity and autoimmunity | 000 | 1 | NIH | 2/5/2026 | $421,223 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA300241 | Targeting mucin-type O-glycosylation for EGFR mutant non-small cell lung cancer | 000 | 1 | NIH | 3/27/2026 | $609,846 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | K99DA060953 | Molecular Regulation of the Kappa Opioid Receptor by 14-3-3 gamma | 000 | 1 | NIH | 2/15/2026 | $163,350 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA303071 | Mechansim of RING-between-RING ubiquitin signaling in DNA repair | 000 | 1 | NIH | 6/18/2026 | $482,637 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | S10OD040148 | C-Trap Optical Tweezers System for Single-Molecule Studies | 000 | 1 | NIH | 6/19/2026 | $1,035,946 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21DE035664 | Neuronal-Glial Coupling Mechanisms in Temporomandibular Joint Pain | 000 | 1 | NIH | 7/27/2026 | $433,125 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM163651 | Molecular Mechanisms of BRCA1/2-Mediated Genome Stability Maintenance | 000 | 1 | NIH | 8/28/2026 | $433,976 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21NS146921 | REST Regulation of Gene Expression in Remote Post-Stroke Plasticity | 000 | 1 | NIH | 7/24/2026 | $433,125 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AR086310 | Osteocyte Interactome in mechanotransduction and bone osteogenesis | 000 | 1 | NIH | 8/28/2026 | $496,963 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31DK143733 | Circadian Regulation of Liver-derived Endostatin | 001 | 1 | NIH | 3/20/2026 | $0 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31DK143733 | Circadian Regulation of Liver-derived Endostatin | 000 | 1 | NIH | 3/20/2026 | $39,298 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA305915 | Genome Maintenance by HELZ, a Novel R-loop Resolvase | 000 | 1 | NIH | 8/24/2026 | $659,409 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA310537 | FOXM1-Mediated Regulation of Anti-Tumor Immune Memory and Its Potential as a Target for Therapeutic Vaccination in Triple-Negative Breast Cancer | 000 | 1 | NIH | 8/27/2026 | $55,114 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31AI197805 | Structure and Function of E3 Ligases | 001 | 1 | NIH | 4/13/2026 | $0 |
|
